Inogen Inc Stock Today
| INGN Stock | USD 5.76 0.03 0.52% |
PerformanceWeakest
| Odds Of DistressLow
|
Inogen is selling at 5.76 as of the 13th of February 2026; that is 0.52 percent decrease since the beginning of the trading day. The stock's open price was 5.79. Inogen has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 15th of November 2025 and ending today, the 13th of February 2026. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 14th of February 2014 | Category Healthcare | Classification Health Care |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. The company has 27.15 M outstanding shares of which 818.45 K shares are currently shorted by private and institutional investors with about 3.86 trading days to cover. More on Inogen Inc
Moving together with Inogen Stock
Moving against Inogen Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Inogen Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President | Bart Sanford | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Trump Equities, Obamacare Repeal, Baby Boomer Prospects, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsInogen utilizes debt financing to potentially enhance returns on invested capital. The relationship between total debt and total assets provides valuable insight into Inogen's leverage profile, showing how much of Inogen's resources are funded through borrowing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inogen Inc (INGN) is traded on NASDAQ Exchange in USA and employs 766 people. Inogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 157.19 M. Inogen Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 27.15 M outstanding shares of which 818.45 K shares are currently shorted by private and institutional investors with about 3.86 trading days to cover.
Inogen Inc currently holds about 223.62 M in cash with 5.91 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Inogen Probability Of Bankruptcy
Ownership AllocationInogen Inc has a total of 27.15 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Inogen Ownership Details
Inogen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dafna Capital Management Llc | 2025-06-30 | 605.6 K | |
| Royce & Associates, Lp | 2025-06-30 | 521.7 K | |
| State Street Corp | 2025-06-30 | 513.2 K | |
| Divisadero Street Capital Management, Lp | 2025-06-30 | 455.4 K | |
| Aqr Capital Management Llc | 2025-06-30 | 447.9 K | |
| Federated Hermes Inc | 2025-06-30 | 423.3 K | |
| Jpmorgan Chase & Co | 2025-06-30 | 396.7 K | |
| Jacobs Levy Equity Management, Inc. | 2025-06-30 | 290.4 K | |
| Connor Clark & Lunn Inv Mgmt Ltd | 2025-06-30 | 275.4 K | |
| Blackrock Inc | 2025-06-30 | 1.7 M | |
| Vanguard Group Inc | 2025-06-30 | 1.7 M |
Inogen Historical Income Statement
Inogen Stock Against Markets
Inogen Corporate Management
| Nabil Shabshab | Pres CEO | Profile | |
| Vijay Paliwal | Senior Enablement | Profile | |
| Lorna Williams | Senior Relations | Profile | |
| Adrien Mithalal | Senior Development | Profile | |
| Agnes Lee | VP Planning | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Will Health Care Equipment & Supplies sector continue expanding? Could Inogen diversify its offerings? Factors like these will boost the valuation of Inogen. Market participants price Inogen higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Inogen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.873 | Earnings Share (1.00) | Revenue Per Share | Quarterly Revenue Growth 0.04 | Return On Assets |
Investors evaluate Inogen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Inogen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Inogen's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Inogen's market price signifies the transaction level at which participants voluntarily complete trades.